IBD (Inflammatory Bowel Disease)
54
20
24
13
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.9%
1 terminated out of 54 trials
92.9%
+6.3% vs benchmark
4%
2 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (54)
Efficacy of Melatonin Treatment on Sleep Quality Improvement in Inflammatory Bowel Disease Patients With Clinical Remission: A Randomized Double-Blind Placebo-Controlled Trial
Assessing Interventions of Diet in IBD
Efficacy of PosBion® Postbiotic Supplementation in Adults With Irritable Bowel Syndrome
Nationwide Survey of Telemedicinal Patient Education in IBD
Combined Advanced Targeted Therapy for Inflammatory Bowel Disease
Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
A Phase I Study of INT-210 Capsules in Healthy Adult Subjects (INT-210-I101)
Food Limitations In Crohn's Disease and Ulcerative coliTis
Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients
Pre-Packaged Low-Residue Diet Assisting Bowel Preparation in Patients With Inflammatory Bowel Disease
Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease
Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease
ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects
Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease
Prevalence of Disorders of Gut-Brain-Interaction in Pediatric Patients With In-remission Inflammatory Bowel Disease
MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease
Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome.
Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease
Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease